September 2nd & 3rd, 2009, Winnipeg, Manitoba, Canada
Agenda [432 Kb]

DAY 1 – Wednesday, September 2

OPENING REMARKS:

Speaker:

• The Honourable Leona Aglukkaq, Minister of Health
• Honourable Theresa Oswald, Manitoba Minister of Health
• Dr. David Butler–Jones, Chief Public Health Officer, Public Health Agency of Canada
• Dr. Frank Plummer, Chief Science Advisor, Public Health Agency of Canada

PLENARY SESSION 1: Overview of Severe H1N1

Chair: Dr. Frank Plummer, Chief Science Advisor, Public Health Agency of Canada

• Update and Overview on the Global H1N1 Activity and Management [3.29MB]
  Dr. Charles Penn, World Health Organization
• Update on Canadian H1N1 Epidemic [211Kb]
  Dr. John Spika, PHAC
• Update on Manitoba H1N1 Epidemic
  Dr. Joel Kettner, Manitoba Health
• Modelling the Next Wave
  Dr. Babak Pourbohloul, British Columbia Centre for Disease Control
• Update on Severe Cases [6.38 Mb]
  Dr. Robert Fowler, University of Toronto
• Modelling of Severe Disease [893Kb]
  Dr. Paul Smetanin, Risk Analytica & Dr. David Stiff, Risk Analytica

PLENARY SESSION 2: Severe Disease Epidemic Narratives

Chair: Dr. Anand Kumar, University of Manitoba

• Lessons Learned from Previous Pandemics [8Mb]
  Dr. Marty Cetron, Centers for Disease Control & Prevention
• System Issues: Lessons from SARS [697Kb]
  Dr. Alison McGeer, Mount Sinai Hospital
• Description of Clinical Management and Challenges Experienced in the Community [217Kb] Dr. Adrian Robertson, Manitoba Health
• Description of Clinical Management and Challenges Experienced in Winnipeg ICUs [870Kb] Dr. Anand Kumar, University of Manitoba

PLENARY SESSION 3: Practical Aspects of Epidemic Management

Chair: Dr. Mike Christian, Mount Sinai Hospital

• Shifting the Paradigm: Individual Patient vs. Population Health [545Kb]
  Dr. Thomas Marrie, Dalhousie University
• Infection Control and Prevention [136Kb]
  Dr. Mary Vearncombe, Dalhousie University
• Antivirals, Risk Factors and Vaccination Strategies within Canada [660KB]
  Dr. Barb Law, PHAC

PLENARY SESSION 4: Pandemic Preparedness for Surge Capacity Management

Chair: Dr. Theresa Tam, PHAC

• Federal Surge Capacity - Dr. Michael O’Connor, PHAC
• Ontario Provincial Surge Capacity [1.2Mb] - Dr. Bernard Lawless, Ministry of Health and Long Term Care (Ontario)
• Hospital/Regional Surge Capacity - Dr. Perry Gray, Health Sciences Centre

DAY 2 – Thursday, September 3

BREAKOUT SESSIONS : (8:30 am – 10:00 am)

Key Challenges for the Front Lines of Public Health and Primary Care

Chair: Dr. Ken Scott, Public Health Agency of Canada

• Remote Communities [780Kb] – Dr. Marcus Lem, Health Canada
  Session will provide an overview of the key challenges faced by remote communities in preventing severe diseases and minimizing deaths, including challenges such as isolation, transportation, and application of current recommendations/guidelines that are mainly aimed at urban centres.
• Public Health Challenges [293Kb] – Dr. Bonnie Henry, British Columbia Centre for Disease Control
  Session will provide an overview of the key challenges faced by public health in preventing severe diseases and minimizing deaths, including challenges in application of current recommendations/guidelines on public health /community mitigation measures and public communications.
• Challenges for Primary Care [256Kb] – Dr. Jim Dickinson, University of Calgary
  Session will provide an overview of the key challenges faced by primary care in the early diagnosis and provision of early treatment of persons at increased risk for severe disease, including challenges in program implementation and application of current recommendations/guidelines.

Clinical Issues I: Diagnosis, Clinical Features and Antiviral Therapy

Chair: Dr. Anand Kumar, University of Manitoba

This session will focus on diagnostic, clinical and specific therapy issues specific to novel swine origin H1N1 severe infections as seen in Canada. In particular, presenters have been tasked with focusing on the differences seen in this epidemic infection in comparison to accepted and/or standard views of influenza.

• Diagnosis: Lessons Learned – Current Recommendations vs. Clinical Reality [53Kb]
  Dr. Paul Van Caeseele, Manitoba Health
• Pulmonary manifestations of severe H1N1 disease [2.14Mb]
  Dr. Clare Ramsey, U of M
• Non-pulmonary aspects of severe influenza – Dr. Kendiss Olafson, U of M
• Antiviral Therapy [104Kb] – Dr. Fred Aoki, U of M

Resource Utilization, Triage and Care Delivery

Chair: Dr. Joel Kettner, Manitoba Health

This session will deal with medical ethics, clinical care guidelines, models of care delivery
and regional cooperation.

• Clinical Care Guidelines: From Evidence to Practice
  Dr. Amin Kabani, PHAC
• Triage: Public Health Ethics and Medical Ethics [15.83Mb]
  Dr. Laura Hawryluck, Toronto General Hospital/UHN
• Triage: When the rubber meets the road: Who goes first? [1.9Mb] – Dr. Mike Christian,
  Mount Sinai Hospital
• Severe H1N1: Triage and Delivery of Adult Emergency Room Care [70Kb]
  – Dr. Ricardo Lobato de Faria, Seven Oaks General Hospital
• Severe H1N1: Triage and Delivery of Pediatric Out Patient and Emergency Room Care [975Kb] – Dr. Lynne Warda, The Manitoba Institute of Child Health
• Challenges in Models of Primary Care Delivery [76Kb] – Dr. Bruce Martin, U of M
• Surveillance: Regional Coordination and Cooperation [499Kb] – Dr. Lisa Richards, Manitoba Health

BREAKOUT SESSIONS : (10:30 am – 12:00 pm)

Specific Public Health and Primary Care Strategies

Chair: Dr. Theresa Tam, Public Health Agency of Canada

• Vaccines and vaccine deployment [678Kb] – Dr. Horacio Arruda, Quebec Ministry of Health and Social Services
  Session will provide current thinking on the Canadian vaccine strategy, prioritization of vaccine supply, vaccine effectiveness evaluation, monitoring and reporting of adverse events following immunization.
• Antiviral Strategies [179Kb] – Dr. Gerald Evans, Queens University
  Session will provide current recommendations on early antiviral treatment strategy, targeted post-exposure prophylaxis, implementation considerations, effectiveness evaluation, monitoring and reporting of adverse events.
• Special populations: the high risk and the hard to reach [78Kb] - Dr. Marcia Anderson, Manitoba Health
  Session will include an overview on the key challenges/considerations and practical solutions to address the needs of specific high risk groups (pregnant women, those with chronic medical conditions etc.) and hard to reach populations (remote and isolated communities, aboriginal communities in urban areas, other vulnerable populations).

Clinical Issues II: Specific Management

Chair: Dr. Anand Kumar, University of Manitoba

This session will focus on issues of supportive and non-specific therapy of severe infection and nosocomial transmission/health care worker risk management. Presenters have been asked to emphasize aspects unique to the current outbreak.

• Supportive Management Strategies for severe swine origin H1N1 Pneumonitis [837Kb] – Dr. Faisal Siddiqui, U of M
• Adjunctive therapies – What do you have left when oseltamivir fails [647Kb]
  – Dr. Anand Kumar, U of M
• Infection Prevention & Control Occupational Health & Hygiene Issues [125Kb]
  – Dr. Lynn Johnston, Dalhousie University
• Exposure and Prophylaxis: HCW issues – Dr. Lynn Johnston, Dalhousie University

Severe H1N1 Research: Critical Questions

Chair: Dr. Mike Drebot, Public Health Agency of Canada

This session will focus on various research themes concerning H1N1 infection and severe disease

• Lessons from animal models – Dr. Gary Kobinger, PHAC
• Epidemiologic unknowns in H1N1 infection [165Kb] – Dr. Carole Beaudoin, PHAC
• Vaccines and Antivirals in the community [431Kb] – Dr. Barb Law, PHAC
• Tackling our unknowns through collaborative research [596Kb] - Dr. Ryan Zarychansk, University of Manitobai
• Therapeutics of severe H1N1 disease [2.52Mb] – Dr. Eleanor Fish, University of Toronto
  

PLENARY SESSION 5: H1N1 International Scope – (Midway Ballroom)

Chair: Dr. Graham Tipples, Public Health Agency of Canada

• H1N1 Update – Australia [1.4Mb]
  Dr. Andrew Singer, Department of Health and Ageing, Australia
• H1N1 Update – Chile [5.52Mb]
  Dr. Guillermo Bugedo, Pontifical Catholic University of Chile

PLENARY SESSION 6: Report on Breakouts

Chair: Dr. Graham Tipples, Public Health Agency of Canada

• Key Challenges for the Front Lines of Public Health and Primary Care
  Dr. Ken Scott, PHAC
• Specific public health and primary care strategies
  Dr. Theresa Tam, PHAC
• Clinical Issues I: Diagnosis, Clinical Features and Antiviral Therapy
  Dr. Anand Kumar, University of Manitoba
• Clinical Issues II: Non-specific Support and Health Care Worker Issues
  Dr. Anand Kumar, University of Manitoba
• Resource Utilization, Triage and Care Delivery
  Dr. Joel Kettner, Manitoba Health
• Severe H1N1 Research: Critical Questions
  Dr. Mike Drebot, PHAC

CLOSING REMARKS

Speaker: Dr. Frank Plummer, Chief Science Advisor, PHAC